{"id":"NCT00382031","sponsor":"Genmab","briefTitle":"Zalutumumab in Patients With Non-curable Head and Neck Cancer","officialTitle":"An Open-Labeled Randomized Parallel Group Trial of Zalutumumab, a Human Monoclonal Anti-EGFr Antibody, in Combination With Best Supportive Care (BSC) vs BSC, in Pts With Non-Curable SCCHN Who Have Failed Standard Platinum-Based Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2009-12","completion":"2011-08","firstPosted":"2006-09-28","resultsPosted":"2013-10-15","lastUpdate":"2013-10-15"},"enrollment":286,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Head and Neck Cancer","Squamous Cell Cancer"],"interventions":[{"type":"DRUG","name":"Zalutumumab","otherNames":["Zalutumumab in combination with Best Supportive Care"]},{"type":"OTHER","name":"Control","otherNames":["Best Supportive Care"]}],"arms":[{"label":"zalutumumab","type":"ACTIVE_COMPARATOR"},{"label":"Control","type":"OTHER"}],"summary":"The purpose of this study is to investigate if zalutumumab in combination with Best Supportive Care (BSC) is superior to BSC in non-curable patients with head and neck cancer","primaryOutcome":{"measure":"Overall Survival","timeFrame":"From randomization until death","effectByArm":[{"arm":"Zalutumumab","deltaMin":6.7,"sd":null},{"arm":"Control","deltaMin":5.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":82,"countries":["Belgium","Brazil","Canada","Estonia","France","Hungary","Lithuania","Poland","Russia","Serbia","Sweden","United Kingdom"]},"refs":{"pmids":["21377930"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":180,"n":189},"commonTop":["General disorders and administration site conditions","Skin and subcutaneous tissue disorders","Gastrointestinal disorders","Respiratory, thoracic and mediastinal disorders","Infections and Infestations"]}}